Texan Plus Hospice Service 6704 Vista Trail, Plano, TX, 75024 | |
(214) 227-8619 |
News Archive
Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource. Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.
Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.
Women experience a notable decline in sexual function approximately 20 months before and one year after their last menstrual period, and that decrease continues, though at a somewhat slower rate, over the following five years, according to a study led by a researcher at Wake Forest Baptist Medical Center.
› Verified 6 days ago
Name | Texan Plus Hospice Service |
---|---|
Location | 6704 Vista Trail, Plano, Texas |
Hospice ID | 741604 |
Category | Freestanding Hospice |
Ownership Type | Proprietary - Corporation |
Profit Type | FOR PROFIT |
SSA county code | 390 |
News Archive
Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource. Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.
Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.
Women experience a notable decline in sexual function approximately 20 months before and one year after their last menstrual period, and that decrease continues, though at a somewhat slower rate, over the following five years, according to a study led by a researcher at Wake Forest Baptist Medical Center.
› Verified 6 days ago
NPI Number | 1902329147 |
Organization Name | Crystal Hospice Care Inc |
Address | 6704 Vista Trl Plano, Texas, 75024 |
Phone Number | (214) 226-8164 |
News Archive
Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource. Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.
Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.
Women experience a notable decline in sexual function approximately 20 months before and one year after their last menstrual period, and that decrease continues, though at a somewhat slower rate, over the following five years, according to a study led by a researcher at Wake Forest Baptist Medical Center.
› Verified 6 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource. Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.
Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.
Women experience a notable decline in sexual function approximately 20 months before and one year after their last menstrual period, and that decrease continues, though at a somewhat slower rate, over the following five years, according to a study led by a researcher at Wake Forest Baptist Medical Center.
› Verified 6 days ago
Home Health Aides | 3 |
Counselors | 1 |
Licensed Practical or Vocational Nurses | 2 |
Physicians | 1 |
Registered Nurses | 3 |
Other Personnel | 2 |
Total Employees | 12 |
---|
News Archive
Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource. Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.
Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.
Women experience a notable decline in sexual function approximately 20 months before and one year after their last menstrual period, and that decrease continues, though at a somewhat slower rate, over the following five years, according to a study led by a researcher at Wake Forest Baptist Medical Center.
› Verified 6 days ago
Others | 2 |
Total Volunteers | 2 |
---|
News Archive
Aravive Biologics, Inc. announced today that the U.S. Food and Drug Administration has granted Fast Track Designation to AVB-S6-500 as a potential treatment for platinum-resistant recurrent ovarian cancer.
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, today announced the launch of Malaria Nexus, Elsevier's Global Malaria Resource. Malaria Nexus highlights the latest published research in Malaria, utilizing Elsevier's leading journals in Parasitology, Entomology and Tropical Medicine, including The Lancet-, The Lancet Infectious Diseases, Transactions of the Royal Society of Tropical Medicine and Hygiene, and International Journal for Parasitology.
Living a traumatic experience favours the persistence of fear associated with an aversive stimulus, known as fear conditioning and such effect, in mice, can be suppressed with a single dosis of 7,8-Dihydroxyflavone, a type of flavonoid which boosts the ability to acquire new emotional learnings.
Women experience a notable decline in sexual function approximately 20 months before and one year after their last menstrual period, and that decrease continues, though at a somewhat slower rate, over the following five years, according to a study led by a researcher at Wake Forest Baptist Medical Center.
› Verified 6 days ago
Grace Hospice Location: 730 Avenue F Suite 200, Plano, Texas, 75074 Phone: (214) 227-8619 |
Advance Hospice Care Of America Inc Location: 5208 Village Creek Drive Suite 104, Plano, Texas, 75093 Phone: (214) 227-8619 |
Dependable Hospice Care Location: 7709 San Jacinto Place Suite 201, Plano, Texas, 75024 Phone: (214) 227-8619 |
Anchor Of Hope Hospice Location: 7708 San Jacinto Place Ste 100, Plano, Texas, 75024 Phone: (214) 227-8619 |